National Stress Øut Day, April 14-20, 2013

Shedding light on anxiety disorders while promoting a healthy dialogue around all mental health issues.

During the week of April 14-20, 2013, college students on more than 200 campuses in the United States and Canada are participating in the 8th annual National Stress Øut Day—a nationwide effort to provide pre-finals stress relief and to educate students about the difference between everyday anxiety and anxiety disorders or other mental illness.

Biomarkers of OCD Subtypes Using Brain Imaging

Eligibility Criteria

Ages 18-65
Diagnosed with Obsessive-Compulsive Disorder

State
Connecticut

A number of studies using different techniques have suggested that the neurotransmitter glutamate is present at excessive levels in at least some patients with OCD. This idea has motivated our use of glutamate-modulating drugs in OCD that has not responded to standard therapies. However, the details of how glutamate is out of balance in OCD remain unclear. Likewise, it is unclear whether glutamate dysregulation contributes to all forms of OCD or only to some subtypes.

Novel medication strategies targeting brain mechanisms in pediatric ocd

Eligibility Criteria

• 8 - 20 years

• Genders: both

• Key inclusion criteria: Primary diagnosis of OCD and currently on a stable and adequate dose of an SRI

 

Your child may be eligible to participate in this study if he/she is diagnosed with Obsessive-Compulsive Disorder.

Exclusion Criteria

• Lifetime diagnosis of: psychotic disorder, bipolar disorder, eating disorder, pervasive developmental disorder, mental retardation, or substance/alcohol dependence

• Current diagnosis of major depressive disorder, attention-deficit hyperactivity disorder (ADHD), Tourette’s/Tic Disorder, or substance/alcohol abuse

• Diagnosis of pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS)

• Active Suicidal Ideation

• Hoarding as the primary OCD symptom

• Pregnant, nursing, or planning to become pregnant

State
New York

This study aims to determine whether adding a medication called minocycline to

antidepressant treatment can help reduce symptoms of OCD. This study also aims to

learn more about the brains of children and adolescents with OCD.

 

Your child must be taking a stable dose of a serotonin reuptake inhibitor (SRI) in order to

participate in this study. During the 12 week study period, your child will continue to

Mind Over Moods — Treating Coexisting Depression and Anxiety

Dennis Greenberger, PhD
Founder and Director
Anxiety & Depression Center
Newport Beach, California

Assistant Clinical Professor
Department of Psychiatry
University of California, Irvine, College of Medicine

Dr. Greenberger describes the differences and similarities between symptoms of anxiety and depression, how the disorders are treated, and what patients can expect in treatment.

Attaining and Maintaining Wellness in OCD (#6628)

Eligibility Criteria

You may be eligible if

  • You have OCD.
  • You are between the ages of 18 and 75.
  • You are still having bothersome symptoms while taking one of the medications listed below for OCD.
  • You are interested in receiving no-cost therapy treatment that may improve your symptoms so that you may be able to stop taking your medication.
  • Clomipramine (Anafranil)
  • Fluoxetine (Prozac)
  • Fluvoxamine (Luvox)
  • Sertraline (Zoloft)
  • Paroxetine (Paxil)
  • Citalopram (Celexa)
  • Escitalopram (Lexapro)
State
New York

A research study offering treatment for people who have obsessive-compulsive disorder (OCD) and are currently taking one of the following medications and still have unwanted symptoms:

  • Clomipramine (Anafranil)
  • Fluoxetine (Prozac)
  • Fluvoxamine (Luvox)
  • Sertraline (Zoloft)
  • Paroxetine (Paxil)
  • Citalopram (Celexa)
  • Escitalopram (Lexapro)

The goal of the study is to understand whether patients with OCD on serotonin reuptake inhibitors (SRIs) who achieve wellness from EX/RP can safely discontinue their medication.

Neurobehavioral Tasks in OCD

Eligibility Criteria

You may be eligible if

  • OCD is your primary problem
  • you are between the ages of 18 and 50
  • you are not currently on any psychiatric medications or hormonal birth control
  • you are not pregnant

You must be able to travel to the New York State Psychiatric Institute/Columbia University at 1051 Riverside Drive (at 168th Street) in Manhattan.

 

Exclusion Criteria
  • You are not between the ages of 18 and 50.
  • You are currently on any psychiatric medications or hormonal birth control.
  • You are pregnant.
  • Unable to travel to the New York State Psychiatric Institute/Columbia University at 1051 Riverside Drive (at 168th Street) in Manhattan.
State
New York

A research study comparing patients with OCD to patients with several other disorders to help us understand the differences in the neurocircuitry of the brain across disorders.

This study uses different behavioral tasks and questionnaires to measure participants’ stress reactivity, startle reflexes, and preferences. All information will be kept completely confidential.